Group One Trading’s LENZ Therapeutics LENZ Stock Holding History

Group One Trading’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.6K	Sell	4,500 -3,900	-46%	-$31.4K	﹤0.01%	5848
2026 Q1	$76.9K	Sell	8,400 -2,200	-21%	-$30.9K	﹤0.01%	4946
2025 Q4	$170K	Buy	10,600 +9,000	+563%	+$262K	﹤0.01%	4527
2025 Q3	$74.5K	Buy	+1,600	New	+$58.8K	﹤0.01%	5599
2023 Q3	–	Sell	-6,914	Closed	-$126K	–	8418
2023 Q2	$126K	Buy	6,914 +614	+10%	+$12.3K	﹤0.01%	4390
2023 Q1	$108K	Buy	6,300 +5,143	+445%	+$83.2K	﹤0.01%	4250
2022 Q4	$26.9K	Buy	+1,157	New	+$26.8K	﹤0.01%	5425

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Group One Trading's LENZ Position: Q2 2026 in Review

Group One Trading reduced its LENZ Therapeutics (LENZ) stake by 4.9% in Q2 2026, selling an estimated $1.8K and leaving 4,292 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5881.

Group One Trading first reported a position in LENZ in Q4 2023 and has held it in 5 quarters since. The position peaked at $41.3K in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Group One Trading held 4,292 shares of LENZ Therapeutics worth $24.4K as of Q2 2026.
Group One Trading sold 223 LENZ Therapeutics shares in Q2 2026, an estimated $1.8K.
LENZ Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5881 holding.
Group One Trading first reported a position in LENZ Therapeutics in Q4 2023 and has held it in 5 quarters since.
Group One Trading's LENZ Therapeutics position peaked at $41.3K in Q1 2026.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.